Current and emerging treatment options for postmenopausal osteoporosis.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2008 AND VI 43 AND IP 5
Results: 15
1
2
Selected websites.
- Published in:
- 2008
- Publication type:
- Journal Article
3
First-time generic approvals.
- Published in:
- 2008
- Publication type:
- Journal Article
4
Pipeline preview.
- Published in:
- 2008
- Publication type:
- Journal Article
5
Istradefylline: an adenosine receptor antagonist for the treatment of Parkinson disease.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
6
FDA actions in brief.
- Published in:
- 2008
- Publication type:
- Journal Article
7
Selected websites.
- Published in:
- Formulary, 2008, v. 43, n. 5, p. 180
- Publication type:
- Article
8
Selected literature.
- Published in:
- Formulary, 2008, v. 43, n. 5, p. 180
- Publication type:
- Article
9
Antibiotics.
- Published in:
- Formulary, 2008, v. 43, n. 5, p. 180
- Publication type:
- Article
10
Current and emerging treatment options for postmenopausal osteoporosis.
- Published in:
- Formulary, 2008, v. 43, n. 5, p. 166
- By:
- Publication type:
- Article
11
Istradefylline: An adenosine receptor antagonist for the treatment of Parkinson disease.
- Published in:
- Formulary, 2008, v. 43, n. 5, p. 157
- By:
- Publication type:
- Article
12
FDA actions in brief.
- Published in:
- Formulary, 2008, v. 43, n. 5, p. 156
- Publication type:
- Article
13
First-time generic approvals.
- Published in:
- Formulary, 2008, v. 43, n. 5, p. 156
- Publication type:
- Article
14
Pipeline preview.
- Published in:
- Formulary, 2008, v. 43, n. 5, p. 156
- Publication type:
- Article
15
New molecular entity: Treanda.
- Published in:
- Formulary, 2008, v. 43, n. 5, p. 156
- Publication type:
- Article